Сравнение компаний

О компании

Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.

Выручка

$42.6B

Сигнал разрыва новостей

Институциональные сигналы

Каскадные паттерны

Ключевые связи

О компании

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Выручка

$130.5B

Сигнал разрыва новостей

Институциональные сигналы

Каскадные паттерны

Ключевые связи